IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Asston Pharmaceuticals IPO listing date & price

BBSMEBSEListed

Listed at

119

3.25%

Asston Pharmaceuticals IPO is a SME book building IPO. Price band is ₹123 per share. Minimum investment is ₹2.46 L. Lot size is 1000 shares. Open from 9 Jul 2025 to 11 Jul 2025. Allotment on 14 Jul 2025. Listing on 16 Jul 2025 at BSE. Managed by Sobhagya Capital Options Ltd Registrar: Maashitla Securities Private Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Asston Pharmaceuticals IPO listing date & price

BBSMEBSEListed

Listed at

119

3.25%

Official documents: RHP and DRHP.

Asston Pharmaceuticals IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹119

Vs issue price

-3.25%

Loss

Issue price

₹123

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.

Asston Pharmaceuticals IPO listing FAQs

How listing price and listing performance work.

What is the Asston Pharmaceuticals IPO listing price?

The Asston Pharmaceuticals IPO listing price is the price at which the company's shares are listed on the stock exchange after the IPO allotment process. It may be at a premium or discount to the issue price depending on market demand and sentiment.

When is the Asston Pharmaceuticals IPO listing date?

The Asston Pharmaceuticals IPO listing date is the date when the company's shares are listed on the stock exchanges (NSE/BSE) and become available for trading. It is usually announced after the allotment process is completed.

What is the Asston Pharmaceuticals IPO allotment date?

The Asston Pharmaceuticals IPO allotment date is when the company finalizes share allocation to applicants. After allotment, you can check your status on the registrar's portal using your application number, PAN, or DP ID.

What is listing gain or loss in Asston Pharmaceuticals IPO?

Listing gain or loss is the difference between the listing price and the issue price. A positive listing gain means the share listed above the issue price; a loss means it listed below. Past listing performance does not guarantee future results.

Where can I check Asston Pharmaceuticals IPO allotment status?

You can check Asston Pharmaceuticals IPO allotment status on the registrar's website or the exchange portal once allotment is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your allotment.

How is the Asston Pharmaceuticals IPO listing price determined?

The Asston Pharmaceuticals IPO listing price is determined by market demand and supply on the listing day. Factors include subscription response, company fundamentals, sector sentiment, and overall market conditions.

Can the Asston Pharmaceuticals IPO listing price differ from the issue price?

Yes, the Asston Pharmaceuticals IPO listing price can be different from the issue price. It may list at a premium (above issue price) or at a discount (below issue price) depending on market conditions at the time of listing.

How is listing performance calculated for Asston Pharmaceuticals IPO?

Listing performance for Asston Pharmaceuticals IPO is calculated as the percentage change from the issue price to the listing price. It is for informational purposes only and does not guarantee similar outcomes for other IPOs.